Grading of laboratories on CD4+ T-lymphocyte evaluations based on acceptable data boundaries defined by the measurement error

Clinical Cytometry

Volumn 50, Issue 2, 2002, Pages 117-126

  Kunkl, Annalisa ^a   Risso, Domenico ^b   Terranova, Maria Paola ^a   Girotto, Mauro ^c   Brando, Bruno ^d   Mortara, Lorenzo ^a   Lantieri, Pasquale Bruno ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Immunohematology Service   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

CD4+ evaluation; Laboratory of excellence; Measurement error; Quality assessment

Indexed keywords

ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CONFIDENCE INTERVAL; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MONITORING; LABORATORY TEST; MEASUREMENT ERROR; PRIORITY JOURNAL; QUALITY CONTROL; REGRESSION ANALYSIS; SCORING SYSTEM; UNITED KINGDOM; ACCURACY; CD4 LYMPHOCYTE COUNT; LABORATORY; MONITORING; STATISTICAL ANALYSIS; CLINICAL CHEMISTRY; CYTOLOGY; IMMUNOPHENOTYPING; METHODOLOGY; REPRODUCIBILITY; STANDARD; STATISTICS;

HUMAN IMMUNODEFICIENCY VIRUS;

CD4-POSITIVE T-LYMPHOCYTES; CHEMISTRY, CLINICAL; HUMANS; IMMUNOPHENOTYPING; LABORATORIES; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; STATISTICS;

EID: 0037092071     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.10069     Document Type: Article

References (42)

1. CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescent and adults. MMWR 1995;41:1-35.
2. Fei DT, Paxton H, Chen AB. Difficulties in precise quantitation of CD4+ T lymphocytes for clinical trials: a review. Biologicals 1993; 21:221-231.
3. Nicholson JK. Quality control in immunophenotyping: U.S. efforts to establish common methodology and their impact. American Society for Histocompatibility and Immunogenetics. Eur J Histochem 1994;38 Suppl 1:7-12.
4. Fletcher MA, Azen SP, Adelsberg B, Gjerset G, Hassett J, Kaplan J, Niland JC, Odom-Maryon T, Parker JW, Stites DP, Mosley JW and the Transfusion Safety Study Group. Immunophenotyping in a multicenter study: the Transfusion Safety Study experience. Clin Immunol Immunopathol 1989;52:38-47.
5. Paxton H, Kidd P, Landay A, Giorgi J, Flomenberg N, Walker E, Valentine F, Fahey J, Gelman R. Results of the flow cytometry ACTG quality control program: analysis and findings. Clin Immunol Immunopathol 1989;52:68-84.
6. Rickman WJ, Waxdal MJ, Monical C, Damato JD, Burke DS. Department of Army lymphocyte immunophenotyping quality assurance program. Clin Immunol Immunopathol. 1989;52:85-95.
7. Martini E, D'Hautcourt JL, Brando B, Lawry J, O'Connor JE, Sansonetty F. First European Quality Control of cellular phenotyping by flow cytometry. Paris: Frison-Roche; 1990.
8. Gerber AR. Centers for Disease Control programs in flow cytometric immunophenotyping. Ann N Y Acad Sci 1993;677:40-42.
9. Homburger HA, Rosenstock W, Paxton H, Paton ML, Landay AL. Assessment of interlaboratory variability of immunophenotyping. Results of the College of American Pathologists flow cytometry survey. Ann N Y Acad Sci 1993;677:43-49.
10. Brando B, Sommaruga E. Nationwide quality control trial on lymphocyte immunophenotyping and flow cytometer performance in Italy. Cytometry 1993;14:294-306.
11. Barnett D, Granger V, Mayr P, Storie I, Wilson GA, Reilly JT. Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: results from the UK NEQAS immune monitoring scheme. Cytometry 1996;26:216-222.
12. Vesely R, Banhs J, Vanlangendonck F, Hannet I, Strauss K. Initial results of Central European Immunophenotyping Quality Control Program (CEQUAL). Cytometry 1996;26:108-112.
13. Gratama JW, Kraan J, Van den Beemd R, Hooibrink B, Van Bockstaele DR, Hooijkaas H. Analysis of variation in results of flow cytometric lymphocyte immunophenotyping in a multicenter study. Cytometry 1997;30:166-177.
14. Pandolfi F, Alario C, Girardi E, Rava L, Ippolito G, Kunkl A, Aiuti F. The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group. Clin Exp Immunol 1998;111:564-573.
15. Bergeron M, Faucher S, Minkus T, Lacroix F, Ding T, Phaneuf S, Somorjai R, Summers R, Mandy F. Impact of unified procedures as implemented in the Canadian Quality Assurance Program for T lymphocyte subset enumeration. Participating Flow Cytometry Laboratories of the Canadian Clinical Trials Network for HIV/AIDS Therapies. Cytometry 1998;33:146-155.
16. Baudouin F, Sarda MN, Goguel A, Bene MC. Multicenter study of reference stabilized human blood for lymphocyte immunophenotyping quality control in flow cytometry. GEIL. Cytometry 1999;38:127-132.
17. Batjer JD. The College of American Pathologists Laboratory Accreditation Programme. Clin Lab Haematol 1990;12 (suppl 1):135-138.
18. CLIA Program; simplifying CLIA regulations relating to accreditation, exemption of laboratories under a state licensure program, proficiency testing and inspection-HCFA. Final rule. Fed Regist 1998;63: 26722-26738.
19. Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993;14:702-715.
20. The Adult AIDS Clinical Trials Group (AACTG). Immunology Quality Assessment Program: program description and certification criteria. http://aactg.s-3.com/iqa.htm.
21. Gelman R, Cheng SC, Kidd P, Waxdal M, Kagan J. Assessment of the effects of instrumentation, monoclonal antibody, and fluorochrome on flow cytometric immunophenotyping: a report based on 2 years of the NIAID DAIDS flow cytometry quality assessment program. Clin Immunol Immunopathol 1993;66:150-162.
22. Mildvan D, Landay A, De Gruttola V, Machado SG, Kagan J. An approach to the validation of markers for use in AIDS clinical trials. Clin Infect Dis 1997;24:764-774.
23. Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998;351:1682-1686.
24. 1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections. Centers for Disease Control and Prevention. MMWR 1994; 43:1-21.
25. Manca F, Li Pira G, Fenoglio D, Valle MT, Kunkl A, Ferraris A, Lancia F, Saverino D, Mortara L, Balderas R, Arp J, Dekaban G, Dalgleish AG, Lozzi L, Theofilopoulos AN. Recognition of human T-leukemia virus (HTLV-1) envelope by human CD4+ T-cell lines from HTLV-1 seronegative individuals: specificity and clonal heterogeneity. Blood 1995;85:1547-1554.
26. Kunkl A, Mortara L, Valle MT, Fenoglio D, Terranova MP, Megiovanni AM, Alessandrini A, Li Pira G, Mazzarello G, Del Bono V, Canessa A, Bassetti D, Manca F. Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons. J Infect Dis 1998;178:488-496.
27. Kunkl A, Valle MT, Fenoglio D, Manca F. Quality control in immunophenotyping use of human CD4+ and CD8+ T clones as standards. Ann N Y Acad Sci 1993;677:417-419.
28. Kunkl A, Valle MT, Fenoglio D, Manca F. Accuracy assessment in flow cytometry quality control: use of cloned human T-lymphocytes as cellular standard. FCS Forum 1993;5:3-5.
29. Girotto M, Facco G, Carubia F, Garbaccio Ioria G, Guerra MG, Lanteri M, Mari R, Saitta M, Mazzucco L. Fenotipizzazione linfocitaria: programma sperimentale di controllo di qualità interlaboratori. La Trasfusione del Sangue 1989;24:227-229 (Italian).
30. Girotto M, Facco G. T-lymphocyte immunophenotyping: 6 years of quality control experience (abstract). Eur J Histochem 1993;37:28.
31. Healy MJR. Outliers in clinical chemistry quality-control schemes. Clin Chem 1979;25:675-677.
32. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
33. rd edition. Oxford: Blackwell Scientific Publication; 1994.
34. Hoover DR, Graham NM, Chen B, Taylor JM, Phair J, Zhou SY, Munoz A. Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J Acquir Immune Defic Syndr 1992;5:794-802.
35. Vedhara K, Nott KH, Richards SM. Individual variability in the reliability of CD4+ cell counts. AIDS 1995;9:98-99.
36. Lyles RH, Munoz A, Xu J, Taylor JM, Chmiel JS. Adjusting for measurement error to assess health effects of variability in biomarkers. Multicenter AIDS Cohort Study. Stat Med 1999;18:1069-1086.
37. Brando B, Barnett D, Janossy G, Mandy F, Autran B, Rothe G, Scarpati B, D'Avanzo GJL, Lenkei R, Schmitz G, Kunkl A, Chianese R, Papa S, Gratama JW. Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. Cytometry 2000;42:327-346.
38. Reimann KA, O'Gorman MR, Spritzler J, Wilkening CL, Sabath DE, Helm K, Campbell DE. Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system. The NIAID DAIDS New Technologies Evaluation Group. Clin Diagn Lab Immunol 2000;7:344-351.
39. Barnett D, Granger V, Whitby L, Storie I, Reilly JT. Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: the way forward. Br J Haematol 1999;106:1059-1062.
40. Schnizlein-Bick CT, Spritzler J, Wilkening CL, Nicholson JK, O'Gorman MR. Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group. Clin Diagn Lab Immunol 2000;7: 336-343.
41. Gelman R, Wilkening C. Analyses of quality assessment studies using CD45 for gating lymphocytes for CD3+4+%. Cytometry 2000;42: 1-4.
42. O'Gorman MR, Nicholson JK. Adoption of single-platform technologies for enumeration of absolute T-lymphocyte subsets in peripheral blood. Clin Diagn Lab Immunol 2000;7:333-335.